Medindia

X

ARIKACE™ Demonstrates Sustained Benefit in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections

Thursday, June 17, 2010 Hospital News J E 4
Advertisement
Data Presented at the European Cystic Fibrosis Society Conference

CONTACT:

Nick Gurreri

917-655-8850

ngurreri@transaveinc.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Profil Institute for Clinical Research Appoints Pr...
S
Community Partnerships Launch 'Tobacco Free Outdoo...